A critical advance in cancer investigation is occurring with the use of mini-antibodies to restore damaged p53. This crucial cancer inhibitor protein is frequently inactivated in several kinds of tumors, leading https://macrobookmarks.com/story22087380/nanobodies-reactivate-tumor-suppressor-p53-new-potential-pathway-for-malignant-management